{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T20:02:33Z","timestamp":1776024153148,"version":"3.50.1"},"reference-count":45,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"abstract":"<jats:p>Myopathy is a disease characterized by muscle dysfunction in general and may be associated with genetics, medication such as statins, or inflammation. In 2019, an epidemic viral infection (SARS-CoV-2 virus) that invaded most countries worldwide appeared and caused acute respiratory disease. Consequently, patients had to take a group of drugs for a relatively long treatment period. According to several studies, there was an increase in the cases of muscular disorders due to several factors. This study aimed to (1) investigate the relationship between COVID-19 and myopathy and (2) identify the causes and prevention methods. A systematic review was conducted, analyzing several articles from the following databases: ResearchGate, Medline, DOAJ (The Directory of Open-Access Journals), PubMed, and Google Scholar. After performing the search and filtering the results, we included 61 articles. There was a strong relationship between COVID-19 and myopathy, especially in patients admitted to the ICU department, due to medication or neurological dysregulation with multiorgan dysfunctions such as polyneuropathy, peripheral nerve involvement, dysautonomia, Guillain-Barr\u00e9 syndrome, and many others.<\/jats:p>","DOI":"10.25122\/jml-2022-0167","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T05:46:17Z","timestamp":1683524777000},"page":"1458-1463","source":"Crossref","is-referenced-by-count":25,"title":["The role of COVID-19 in myopathy: incidence, causes, treatment, and prevention"],"prefix":"10.25122","volume":"15","author":[{"given":"Manal","family":"Awad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Family Physician (CCFP), Madigan Medical Centre, Calgary, Alberta, Canada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany Akeel","family":"Al-hussaniy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Pharmacology, College of Medicine, University of Baghdad, Baghdad, Iraq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Dr. Hany Akeel Institute, Iraqi Medical Research Center, Baghdad, Iraq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"* Corresponding Author: Hany Akeel AL-hussaniy, Department of Pharmacology, College of Medicine, University of Baghdad, Baghdad, Iraq. E-mail: hany_akeel2000@yahoo.com","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Hikmat","family":"Alburghaif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Pharmacy, Ashur University College, Baghdad, Iraq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam Turath","family":"Tawfeeq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Pathology, College of Medicine, University of Mosul, Mosul, Iraq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","published-online":{"date-parts":[[2022,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Mukund K, Subramaniam S. Skeletal muscle: A review of molecular structure and function, in health and disease. Wiley Interdiscip Rev Syst Biol Med. 2020;12(1):e1462. http:\/\/dx.doi.org\/10.1002\/wsbm.1462","DOI":"10.1002\/wsbm.1462"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Danielsson O, H\u00e4ggqvist B. Skeletal muscle immunohistochemistry of acquired and hereditary myopathies. Curr Opin Rheumatol. 2021 Nov 1;33(6):529-536. doi: 10.1097\/BOR.0000000000000828","DOI":"10.1097\/BOR.0000000000000828"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Dubowitz V. What's in a name? Muscular dystrophy revisited. European Journal of Paediatric Neurology. 1998;2(6):279-84. https:\/\/doi.org\/10.1016\/ S1090-3798(98)80001-9","DOI":"10.1016\/S1090-3798(98)80001-9"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Rayavarapu S, Coley W, Kinder TB, Nagaraju K. Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness. Skelet Muscle. 2013;3(1):13. doi: 10.1186\/2044-5040-3-13.","DOI":"10.1186\/2044-5040-3-13"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Al-hussaniy HA, Altalebi RR, Tylor FM, Alwash AH, et al. Leptin Hormone: In Brief. Med Pharm J. 2022;1(1):1\u20133. Doi:10.55940\/medphar20221","DOI":"10.55940\/medphar20221"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Thabet Mahmoud A, Tawfik MA, Abd El Naby SA, Abo El Fotoh WM, et al. Neurophysiological study of critical illness polyneuropathy and myopathy in mechanically ventilated children; additional aspects in paediatric critical illness comorbidities. European Journal of Neurology. 2018;25(7):991-e76. DOI: 10.1111\/ene.13649","DOI":"10.1111\/ene.13649"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Shepherd S, Batra A, Lerner DP. Review of critical illness myopathy and neuropathy. Neurohospitalist. 2017;7(1):41\u20138. http:\/\/dx.doi. org\/10.1177\/1941874416663279","DOI":"10.1177\/1941874416663279"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Tankisi H, de Carvalho M, Z'Graggen WJ. Critical illness neuropathy. Journal of Clinical Neurophysiology. 2020;37(3):205-7. DOI: 10.1097\/ wnp.0000000000000658","DOI":"10.1097\/WNP.0000000000000658"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Intiso D, Centra AM, Giordano A, Santamato A, et al. Critical illness polyneuropathy and functional outcome in subjects with COVID-19: Report on four patients and a scoping review of the literature. J Rehabil Med. 2022;54:jrm00257. DOI: 10.2340\/jrm.v53.1139","DOI":"10.2340\/jrm.v53.1139"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Abdulameer AA, Mohammed ZN, Tawfeeq KT. Endoscopic characteristics and management of Subepithelial Lesions in Video-Gastascopie. Med Pharm J. 2022;1(1):4\u201313. DOI: 10.55940\/medphar20222","DOI":"10.55940\/medphar20222"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Cheung K, Rathbone A, Melanson M, Trier J, et al. Pathophysiology and management of critical illness polyneuropathy and myopathy. Journal of Applied Physiology. 2021 May 1;130(5):1479-89. DOI: 10.1152\/ japplphysiol.00019.2021","DOI":"10.1152\/japplphysiol.00019.2021"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Versace V, Sebastianelli L, Ferrazzoli D, Saltuari L, et al. Case report: Myopathy in critically ill COVID-19 patients: A consequence of hyperinflammation? Front Neurol. 2021;12:625144. DOI:\/10.3389\/fneur.2021.625144.","DOI":"10.3389\/fneur.2021.625144"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Naji MA, Alburghaif AH, Saleh NK. Patient expectations regarding consultation with a family doctor: a cross-sectional study. Med Pharm J. 2022;1(1):35\u201340. DOI:10.55940\/medphar20225","DOI":"10.55940\/medphar20225"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Villa D, Ardolino G, Borellini L, Cogiamanian F, et al. Subclinical myopathic changes in COVID-19. Neurological Sciences. 2021;42(10):3973-9. DOI: 10.1007%2Fs10072-021-05469-8","DOI":"10.1007\/s10072-021-05469-8"},{"key":"ref15","unstructured":"15. ALZobaidy MA, AlbuRghaif AH, Alhasany HA, Naji MA. Angiotensinconverting enzyme inhibitors may increase the risk of severe COVID-19 infection. Annals of the Romanian Society for Cell Biology. 2021;25(6): 17843\u201317849."},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE. Neutrophil Extracellular Traps (NETs) and COVID-19: A new frontiers for therapeutic modality. Int Immunopharmacol. 2022 Mar;104:108516. doi: 10.1016\/j.intimp.2021.108516","DOI":"10.1016\/j.intimp.2021.108516"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Vrettou CS, Mantziou V, Vassiliou AG, Orfanos SE, et al. Post-intensive care syndrome in survivors from critical illness including COVID-19 patients: A narrative review. Life (Basel). 2022;12(1):107. http:\/\/dx.doi.org\/10.3390\/ life12010107","DOI":"10.3390\/life12010107"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Ercegovac M, Asanin M, Savic-Radojevic A, Ranin J, et al. Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID. Antioxidants. 2022;11(5):954. doi: 10.3390\/antiox11050954.","DOI":"10.3390\/antiox11050954"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Riquelme C, Acu\u00f1a MJ, Torrej\u00f3n J, Rebolledo D, et al. ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis. PloS one. 2014;9(4):e93449.","DOI":"10.1371\/journal.pone.0093449"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Seixas MLGA, Mitre LP, Shams S, Lanzuolo GB, et al. Unraveling muscle impairment associated with COVID-19 and the role of 3D culture in its investigation. Front Nutr. 2022 Feb 10;9:825629. doi: 10.3389\/ fnut.2022.825629.","DOI":"10.3389\/fnut.2022.825629"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Gonzalez A, Orozco-Aguilar J, Achiardi O, Simon F, Cabello-Verrugio C. SARS-CoV-2\/Renin-Angiotensin System: Deciphering the Clues for a Couple with Potentially Harmful Effects on Skeletal Muscle. Int J Mol Sci. 2020;21(21):7904. doi: 10.3390\/ijms21217904.","DOI":"10.3390\/ijms21217904"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Yoshida T, Delafontaine P. Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells. 2020 Aug 26;9(9):1970. doi: 10.3390\/cells9091970.","DOI":"10.3390\/cells9091970"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. Cabello-Verrugio C, C\u00f3rdova G, Salas JD. Angiotensin II: role in skeletal muscle atrophy. Curr Protein Pept Sci. 2012 Sep;13(6):560-9. doi: 10.2174\/138920312803582933","DOI":"10.2174\/138920312803582933"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Kingsley J, Torimoto K, Hashimoto T, Eguchi S. Angiotensin II inhibition: a potential treatment to slow the progression of sarcopenia. Clin Sci (Lond). 2021 Nov 12;135(21):2503-2520. doi: 10.1042\/CS20210719","DOI":"10.1042\/CS20210719"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Al-hassany HA, Albu-rghaif AH, A. Naji M. Tumor diagnosis by genetic markers protein P-53, p16, C-MYC, N-MYC, protein K-Ras, and gene her- 2 Neu is this possible? Pakistan Journal of Medical and Health Sciences. 2021;15(8):2350\u20134.","DOI":"10.53350\/pjmhs211582350"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020 Jul;194:105921. doi: 10.1016\/j. clineuro.2020.105921","DOI":"10.1016\/j.clineuro.2020.105921"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, et al. The ACE2\/Angiotensin-(1-7)\/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). Physiol Rev. 2018;98(1):505-553. doi: 10.1152\/ physrev.00023.2016","DOI":"10.1152\/physrev.00023.2016"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Al-hussaniy HA, Altalebi RR, Alburagheef A, Abdul-Amir AG. The Use of PCR for Respiratory Virus Detection on the Diagnosis and Treatment Decision of Respiratory Tract Infections in Iraq. J Pure Appl Microbiol. 2022;16(1):201-206.","DOI":"10.22207\/JPAM.16.1.10"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. McWilliams D, Weblin J, Hodson J, Veenith T, et al. Rehabilitation levels in patients with COVID-19 admitted to intensive care requiring invasive ventilation. An observational study. Ann Am Thorac Soc. 2021;18(1):122-9.","DOI":"10.1513\/AnnalsATS.202005-560OC"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. Al-Juhaishi AM, Aziz ND. Safety and Efficacy of antiviral drugs against COVID19 infection: an updated systemic review. Medical and Pharmaceutical Journal. 2022;1(2):45-55.","DOI":"10.55940\/medphar20226"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"31. Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268(4):1133-1170. DOI:10.1007\/s00415-020-10124-x.","DOI":"10.1007\/s00415-020-10124-x"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. Bagnato S, Boccagni C, Marino G, Prestandrea C, et al. Critical illness myopathy after COVID-19. International Journal of Infectious Diseases. 2020;99:276-8.","DOI":"10.1016\/j.ijid.2020.07.072"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Al-hussaniy HA, Al-tameemi ZS. Methicillin-Resistant Staphylococcus aureus and New Delhi Metallo beta-lactamases-types of antibiotic resistance, methods of prevention. Med Pharm J. 2022;1(1):14\u201324. DOI: 10.55940\/ medphar20223","DOI":"10.55940\/medphar20223"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Haidar MA, Shakkour Z, Reslan MA, Al-Haj N, et al. SARS-CoV-2 involvement in central nervous system tissue damage. Neural Regen Res. 2022;17(6):1228\u201339. DOI: http:\/\/dx.doi.org\/10.4103\/1673-5374.327323","DOI":"10.4103\/1673-5374.327323"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Caba\u00f1es-Mart\u00ednez L, Villad\u00f3niga M, Gonz\u00e1lez-Rodr\u00edguez L, Araque L, et al. Neuromuscular involvement in COVID-19 critically ill patients. Clin Neurophysiol. 2020;131(12):2809\u201316. DOI:10.1016\/j.clinph.2020.09.017","DOI":"10.1016\/j.clinph.2020.09.017"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. Al-kuraishy AA, Jalil HJ, Mahdi AS, Al-hussaniy HA. General anesthesia in patient with Brain Injury. Med. Pharm. J. 2022;1(1):24-3. DOI: 10.55940\/ medphar20224.","DOI":"10.55940\/medphar20224"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"37. Dietmann A, Ripellino P, Humm AM, Hundsberger T, et al. Hot Topics on COVID-19 and Its Possible Association with Guillain-Barr\u00e9 Syndrome. Clinical and Translational Neuroscience. 2022;6(1):7. https:\/\/doi.org\/ 10.3390\/ctn6010007","DOI":"10.3390\/ctn6010007"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"38. Feier CVI, Muntean C, Bardan R, Olariu A, Olariu S. Impact of COVID-19 pandemic on a general surgery clinic. J Med Life. 2022;15(3):415\u20139. DOI: 10.25122\/jml-2022-0087","DOI":"10.25122\/jml-2022-0087"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"39. Zhou W, Ruksakulpiwat S, Fan Y, Ji L. Nutritional Interventions on Physical Functioning for Critically Ill Patients: An Integrative Review. J Multidiscip Healthc. 2021;14:1489-1507. Doi: 10.2147\/JMDH.S314132.","DOI":"10.2147\/JMDH.S314132"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"40. McGlory C, Calder PC, Nunes EA. The Influence of Omega-3 Fatty Acids on Skeletal Muscle Protein Turnover in Health, Disuse, and Disease. Front Nutr. 2019 Sep 6;6:144. doi: 10.3389\/fnut.2019.00144.","DOI":"10.3389\/fnut.2019.00144"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"41. Sawada Y, Saito-Sasaki N, Nakamura M. Omega 3 Fatty Acid and Skin Diseases. Front Immunol. 2021 Feb 5;11:623052. doi: 10.3389\/ fimmu.2020.623052.","DOI":"10.3389\/fimmu.2020.623052"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"42. Akeel Naji H. The Psychosocial and Economic Impact of Uveitis in Iraq. RABMS. 2021; 7 (4):207-215","DOI":"10.52547\/rabms.7.4.207"},{"key":"ref43","unstructured":"43. Antonescu F, Adam M, Popa C, Tu\u0163\u0103 S. A review of cervical spine MRI in ALS patients. J Med Life. 2018;11(2):123\u20137."},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"44. Parry SM, Berney S, Koopman R, Bryant A, et al. Early rehabilitation in critical care (eRiCC): functional electrical stimulation with cycling protocol for a randomised controlled trial. BMJ open. 2012;2(5):e001891. doi: 10.1136\/bmjopen-2012-001891","DOI":"10.1136\/bmjopen-2012-001891"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"45. Al-Hussaniy HA, Alburghaif AH, Naji MA. Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions. J Med Life. 2021;14(5):600\u20135. Doi: 10.25122\/jml-2021-0153","DOI":"10.25122\/jml-2021-0153"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/2.-jml-2022-0167-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T05:46:33Z","timestamp":1683524793000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/2.-jml-2022-0167-1.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["JMedLife-15-1458"],"URL":"https:\/\/doi.org\/10.25122\/jml-2022-0167","relation":{},"ISSN":["1844-122X","1844-3117"],"issn-type":[{"value":"1844-122X","type":"print"},{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}